Literature DB >> 8255441

MELAS syndrome masquerading as herpes simplex encephalitis.

D R Johns1, A G Stein, R Wityk.   

Abstract

Herpes simplex encephalitis (HSE) is commonly treated empirically with acyclovir without confirmatory brain biopsy. Three consecutive adults with molecularly verified mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome presented with, and were treated for, apparent HSE. MELAS syndrome in adults may present as an atypical, recurrent form of HSE and should be added to the list of neurologic diseases that can mimic HSE.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255441     DOI: 10.1212/wnl.43.12.2471

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome mimicking herpes simplex encephalitis: A case report.

Authors:  Wen-Gao Zeng; Wan-Min Liao; Jue Hu; Su-Fen Chen; Zhen Wang
Journal:  Radiol Case Rep       Date:  2022-05-08

2.  Acute auditory agnosia as the presenting hearing disorder in MELAS.

Authors:  Gabriele Miceli; Guido Conti; Alessandro Cianfoni; Raffaella Di Giacopo; Patrizia Zampetti; Serenella Servidei
Journal:  Neurol Sci       Date:  2008-11-15       Impact factor: 3.307

3.  Late-onset MELAS syndrome with mtDNA 14453G→A mutation masquerading as an acute encephalitis: a case report.

Authors:  Yuki Yokota; Makoto Hara; Takayoshi Akimoto; Tomotaka Mizoguchi; Yu-Ichi Goto; Ichizo Nishino; Satoshi Kamei; Hideto Nakajima
Journal:  BMC Neurol       Date:  2020-06-17       Impact factor: 2.474

4.  Mitochondrial Strokes: Diagnostic Challenges and Chameleons.

Authors:  Chiara Pizzamiglio; Enrico Bugiardini; William L Macken; Cathy E Woodward; Michael G Hanna; Robert D S Pitceathly
Journal:  Genes (Basel)       Date:  2021-10-19       Impact factor: 4.141

5.  Systematic review of cognitive deficits in adult mitochondrial disease.

Authors:  H L Moore; A P Blain; D M Turnbull; G S Gorman
Journal:  Eur J Neurol       Date:  2019-10-22       Impact factor: 6.288

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.